Company intelligence / Profile preview

ScreenCell

Sarcelles, Île-de-France, Francescreencell.com ↗

Ownership: Private
Employees: ~19
Development stage: Commercial

Overview

Over ten years of experience with more than 70,000 filtration units used worldwide. The technology demonstrates a >90% recovery rate for CTCs. Over seventy scientific articles have validated the effectiveness of the platform for cytology, molecular biology, and cell culture applications. No therapeutic clinical trial results as this is a diagnostic/device company.

Therapeutic areas: Oncology
Modalities: Device (liquid biopsy filtration device)Diagnostic technology (for circulating tumor cells)
Industry: Pathology

Partnerships

Not specifically listed; over seventy scientific collaborations/publications by customers and partners using their technology.

Beyond the preview

Go deeper on ScreenCell.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ScreenCell.

Explore the full profile